A new study on humanin was published on October 12, 2026, in the journal Neuroscience. The publication is titled "Humanin attenuates neuronal cellular senescence and preserves neurotransmitter release in differentiated PC12 cells." Humanin remains classified as an unapproved research compound. The title reflects the subject of the study as recorded in the publication record. This brief does not summarize results, outcomes, or conclusions beyond what is stated in the title itself. Researchers and readers interested in the underlying data are encouraged to consult the full publication directly through the listed source. The paper is indexed under PubMed ID 42863694 and is available for review by the scientific community. No additional experimental details, methods, or findings are provided in this notice. As with all research-stage compounds, humanin's status as unapproved for clinical use remains unchanged by this publication. For more background on humanin, including its research history and classification, readers can refer to the compound overview.
Humanin Study Published in Neuroscience on PC12 Cell Senescence
Source: https://pubmed.ncbi.nlm.nih.gov/42863694/